Alan Menter - Concepedia

Author

Alan Menter

Also Known As

A MENTER, A Menter, A. Menter, Alan Menter, Alan Menter, MD, April W. Armstrong, J.Christian Cather, Jashin J. Wu, M A Menter, M Alan Menter

542

Publications

40.2K

Citations

H-Index

123

Concepts

All Affiliations

Baylor University Medical Center Icahn School of Medicine at Mount Sinai Probity Medical Research University of California, San Francisco Northwestern University

About

Alan Menter is an author at Baylor University Medical Center specializing in medicine, dermatology, and psoriatic arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	52	107	17.2K
2	Public Health	3	3	481
3	Health Sciences	2	2	91
4	Engineering	1	1	159
5	Natural Sciences	1	1	70

Alan Menter

207

Publications

30.4K

Citations

H-Index

Page 1

	Year	Citations
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways Rajan P. Nair, Kristina Callis Duffin, Cynthia Helms, Nature Genetics InflammationCytokineImmune Cell DevelopmentMedicineImmune Regulation	2009	1.4K
Guidelines of care for the management of psoriasis and psoriatic arthritis Alan Menter, Alice B. Gottlieb, Steven R. Feldman, Journal of the American Academy of Dermatology RheumatologyMedicineClinical DermatologyDermatologyPsoriatic Arthritis	2008	1.2K
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Gerald G. Krueger, John Koo, Mark Lebwohl, PubMed	2001	977
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis Kim Papp, Craig L. Leonardi, Alan Menter, New England Journal of Medicine	2012	923
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial Alan Menter, Stephen K. Tyring, Kenneth B. Gordon, Journal of the American Academy of Dermatology Autoimmune DiseaseSystemic TreatmentSevere PsoriasisPhase Iii TrialClinical Trials	2007	869
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis C.E.M. Griffiths, Bruce Strober, Peter van de Kerkhof, New England Journal of Medicine	2010	845
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials C.E.M. Griffiths, Kristian Reich, Mark Lebwohl, The Lancet Randomised TrialsClinical TrialsClinical DermatologyDermatologyExperimental Dermatology	2015	815
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis Mark Lebwohl, Bruce Strober, Alan Menter, New England Journal of Medicine	2015	790
Guidelines of care for the management of psoriasis and psoriatic arthritis Alice B. Gottlieb, Neil J. Korman, Kenneth B. Gordon, Journal of the American Academy of Dermatology RheumatologyMedicineClinical DermatologyDermatologyPsoriatic Arthritis	2008	763
European S3‐Guidelines on the systemic treatment of psoriasis vulgaris Delano Pathirana, AD Ormerod, P. Saïag, Journal of the European Academy of Dermatology and Venereology	2009	695

Page 1